{"id":44221,"date":"2022-05-23T17:01:26","date_gmt":"2022-05-23T15:01:26","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/howie-mandel-joins-nocd-to-change-the-ocd-conversation\/"},"modified":"2022-05-23T17:01:26","modified_gmt":"2022-05-23T15:01:26","slug":"howie-mandel-joins-nocd-to-change-the-ocd-conversation","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/howie-mandel-joins-nocd-to-change-the-ocd-conversation\/","title":{"rendered":"Howie Mandel Joins NOCD to Change the OCD Conversation"},"content":{"rendered":"
\n

\nMandel joins forces with the world\u2019s leading provider of obsessive-compulsive disorder (OCD) treatment, to tear down barriers to treatment with the #KnowOCD campaign<\/i>\n<\/p>\n

CHICAGO–(BUSINESS WIRE)–#OCD<\/a>–Today, NOCD, the world\u2019s leading provider of obsessive-compulsive disorder (OCD) treatment, announces its partnership with comedian, actor and host, Howie Mandel, in launching the #KnowOCD campaign starting during Mental Health Awareness Month, May 2022. The campaign aims to raise awareness for the underserved global population that suffers from OCD, many of whom are improperly treated for other mental health conditions due to misdiagnosis. Mandel\u2019s partnership with NOCD is a continuation of his longtime commitment to serving the global community of people with OCD. Throughout his illustrious career, Mandel has used his global spotlight to shed light on mental health awareness and share with the world what OCD really is: not a joke or personality quirk, but a potentially debilitating condition.\n<\/p>\n

<\/a><\/p>\n

\n\u201cAfter so much mental suffering throughout most of my life, it was a gift, first, to identify my issue as OCD. Once I was diagnosed, my journey to becoming a highly functioning, productive person could begin. The top two barriers were\u2014and remain\u2014the stigma attached to OCD and the lack of access to high-quality treatment,\u201d says Howie Mandel.\n<\/p>\n

\nNOCD is redefining OCD treatment with access to leading national and regional insurance providers, now available to over one in three Americans as a covered benefit providing a highly effective solution suited to the scale of the OCD community. The company has developed an expert-trained network of OCD specialists and increased global awareness and understanding of OCD.\n<\/p>\n

\nNOCD\u2019s Founder and CEO Stephen Smith says he \u201clooks forward to this partnership as an opportunity to promote the understanding of OCD around the globe.\u201d \u201cOCD is a unique condition in that it\u2019s currently recognized by nearly everyone, but understood by few. I\u2019m confident that alongside Howie Mandel, we\u2019ll redefine OCD\u2019s connotation, reach those who need help the most, bring evidence-based treatment directly to them online, and end global suffering caused by OCD.\u201d\n<\/p>\n

\nNOCD has demonstrated that the new frontier of Community-Driven Therapy can serve large populations of people with debilitating mental health conditions. Inside the NOCD platform, members can receive ongoing, face-to-face teletherapy sessions from licensed NOCD therapists who specialize in OCD treatment. Members can also access twenty-four seven support outside of sessions, including therapist messaging, peer support groups, and self-help tools.\n<\/p>\n

\nNOCD and Howie Mandel are excited to launch the #KnowOCD campaign that will change the way people understand and talk about this debilitating disorder. Join the conversation today! Visit www.KnowOCD.com<\/a> to learn more.\n<\/p>\n

\nAbout NOCD:<\/b>\n<\/p>\n

\nNOCD (https:\/\/www.nocd.com<\/a>) is the #1 telehealth provider for the treatment of obsessive compulsive disorder (OCD) and the leading company driving Community-Driven Therapy, a new frontier in behavioral healthcare that leverages condition-specific peer communities to identify consumers in need of help, encourage them to begin treatment, and serve them in a highly personalized way. The company helps people reclaim their lives with clinically proven OCD treatment by removing barriers to care and reducing the stigma associated with OCD. Inside the NOCD platform, members can quickly access a national network of licensed therapists who specialize in Exposure and Response Prevention (ERP) therapy, the \u201cgold standard\u201d for OCD treatment.\n<\/p>\n

\nWorking together with our therapists, patients, health plans, providers, and employers, we are improving the lives of people with OCD. Please visit our website for more information about NOCD.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nRobert Capobianco
\n
Chief Marketing Officer, NOCD
\n
Robert.capobianco@nocdhelp.com<\/a>
610-952-0327\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Mandel joins forces with the world\u2019s leading provider of obsessive-compulsive disorder (OCD) treatment, to tear down barriers to treatment with the #KnowOCD campaign CHICAGO–(BUSINESS WIRE)–#OCD–Today, NOCD, the world\u2019s leading provider of obsessive-compulsive disorder (OCD) treatment, announces its partnership with comedian, actor and host, Howie Mandel, in launching the #KnowOCD campaign starting during Mental Health Awareness … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-44221","6":"format-standard","7":"category-industry"},"yoast_head":"\nHowie Mandel Joins NOCD to Change the OCD Conversation - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/howie-mandel-joins-nocd-to-change-the-ocd-conversation\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Howie Mandel Joins NOCD to Change the OCD Conversation - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Mandel joins forces with the world\u2019s leading provider of obsessive-compulsive disorder (OCD) treatment, to tear down barriers to treatment with the #KnowOCD campaign CHICAGO–(BUSINESS WIRE)–#OCD–Today, NOCD, the world\u2019s leading provider of obsessive-compulsive disorder (OCD) treatment, announces its partnership with comedian, actor and host, Howie Mandel, in launching the #KnowOCD campaign starting during Mental Health Awareness ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/howie-mandel-joins-nocd-to-change-the-ocd-conversation\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-05-23T15:01:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220523005727\/en\/1463968\/21\/NOCD_1206354.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/howie-mandel-joins-nocd-to-change-the-ocd-conversation\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/howie-mandel-joins-nocd-to-change-the-ocd-conversation\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Howie Mandel Joins NOCD to Change the OCD Conversation\",\"datePublished\":\"2022-05-23T15:01:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/howie-mandel-joins-nocd-to-change-the-ocd-conversation\\\/\"},\"wordCount\":599,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/howie-mandel-joins-nocd-to-change-the-ocd-conversation\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220523005727\\\/en\\\/1463968\\\/21\\\/NOCD_1206354.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/howie-mandel-joins-nocd-to-change-the-ocd-conversation\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/howie-mandel-joins-nocd-to-change-the-ocd-conversation\\\/\",\"name\":\"Howie Mandel Joins NOCD to Change the OCD Conversation - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/howie-mandel-joins-nocd-to-change-the-ocd-conversation\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/howie-mandel-joins-nocd-to-change-the-ocd-conversation\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220523005727\\\/en\\\/1463968\\\/21\\\/NOCD_1206354.jpg\",\"datePublished\":\"2022-05-23T15:01:26+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/howie-mandel-joins-nocd-to-change-the-ocd-conversation\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/howie-mandel-joins-nocd-to-change-the-ocd-conversation\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/howie-mandel-joins-nocd-to-change-the-ocd-conversation\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220523005727\\\/en\\\/1463968\\\/21\\\/NOCD_1206354.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220523005727\\\/en\\\/1463968\\\/21\\\/NOCD_1206354.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/howie-mandel-joins-nocd-to-change-the-ocd-conversation\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Howie Mandel Joins NOCD to Change the OCD Conversation\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Howie Mandel Joins NOCD to Change the OCD Conversation - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/howie-mandel-joins-nocd-to-change-the-ocd-conversation\/","og_locale":"en_US","og_type":"article","og_title":"Howie Mandel Joins NOCD to Change the OCD Conversation - Pharma Trend","og_description":"Mandel joins forces with the world\u2019s leading provider of obsessive-compulsive disorder (OCD) treatment, to tear down barriers to treatment with the #KnowOCD campaign CHICAGO–(BUSINESS WIRE)–#OCD–Today, NOCD, the world\u2019s leading provider of obsessive-compulsive disorder (OCD) treatment, announces its partnership with comedian, actor and host, Howie Mandel, in launching the #KnowOCD campaign starting during Mental Health Awareness ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/howie-mandel-joins-nocd-to-change-the-ocd-conversation\/","og_site_name":"Pharma Trend","article_published_time":"2022-05-23T15:01:26+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220523005727\/en\/1463968\/21\/NOCD_1206354.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/howie-mandel-joins-nocd-to-change-the-ocd-conversation\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/howie-mandel-joins-nocd-to-change-the-ocd-conversation\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Howie Mandel Joins NOCD to Change the OCD Conversation","datePublished":"2022-05-23T15:01:26+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/howie-mandel-joins-nocd-to-change-the-ocd-conversation\/"},"wordCount":599,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/howie-mandel-joins-nocd-to-change-the-ocd-conversation\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220523005727\/en\/1463968\/21\/NOCD_1206354.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/howie-mandel-joins-nocd-to-change-the-ocd-conversation\/","url":"https:\/\/pharma-trend.com\/en\/howie-mandel-joins-nocd-to-change-the-ocd-conversation\/","name":"Howie Mandel Joins NOCD to Change the OCD Conversation - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/howie-mandel-joins-nocd-to-change-the-ocd-conversation\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/howie-mandel-joins-nocd-to-change-the-ocd-conversation\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220523005727\/en\/1463968\/21\/NOCD_1206354.jpg","datePublished":"2022-05-23T15:01:26+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/howie-mandel-joins-nocd-to-change-the-ocd-conversation\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/howie-mandel-joins-nocd-to-change-the-ocd-conversation\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/howie-mandel-joins-nocd-to-change-the-ocd-conversation\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220523005727\/en\/1463968\/21\/NOCD_1206354.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220523005727\/en\/1463968\/21\/NOCD_1206354.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/howie-mandel-joins-nocd-to-change-the-ocd-conversation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Howie Mandel Joins NOCD to Change the OCD Conversation"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44221","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=44221"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44221\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=44221"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=44221"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=44221"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}